Matches in Nanopublications for { ?s ?p "[Protease-activated receptor-1 (PAR-1) and PAR-2 are overexpressed in cancer cells and activation of these receptors contributes to malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP750326.RA5RmOBt0JkUQc035eGToZqJGJ5HjZ_0B862M0c36dZxc130_assertion description "[Protease-activated receptor-1 (PAR-1) and PAR-2 are overexpressed in cancer cells and activation of these receptors contributes to malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750326.RA5RmOBt0JkUQc035eGToZqJGJ5HjZ_0B862M0c36dZxc130_provenance.
- NP390265.RASb4nJXjfB0LQKTfDB62aSfxgbcJFLsuic7dCtajR8x0130_assertion description "[Protease-activated receptor-1 (PAR-1) and PAR-2 are overexpressed in cancer cells and activation of these receptors contributes to malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390265.RASb4nJXjfB0LQKTfDB62aSfxgbcJFLsuic7dCtajR8x0130_provenance.
- NP390352.RAdNdNL0nKOQAQ_zQAMsihqxiuNPAFrKHxw_1gzmsjdVE130_assertion description "[Protease-activated receptor-1 (PAR-1) and PAR-2 are overexpressed in cancer cells and activation of these receptors contributes to malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390352.RAdNdNL0nKOQAQ_zQAMsihqxiuNPAFrKHxw_1gzmsjdVE130_provenance.
- NP808717.RAyMte8qGhRif7U201dIdFRdx1nMP8Xat1Nuq8JSCgiPE130_assertion description "[Protease-activated receptor-1 (PAR-1) and PAR-2 are overexpressed in cancer cells and activation of these receptors contributes to malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808717.RAyMte8qGhRif7U201dIdFRdx1nMP8Xat1Nuq8JSCgiPE130_provenance.
- NP809118.RA87df9U3WJp1uiAnnMLasJRMrpqlzph03WQIImi-EjsA130_assertion description "[Protease-activated receptor-1 (PAR-1) and PAR-2 are overexpressed in cancer cells and activation of these receptors contributes to malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809118.RA87df9U3WJp1uiAnnMLasJRMrpqlzph03WQIImi-EjsA130_provenance.
- NP390531.RAKgAvnJ_zTfnbA9oLtOgrsVJK4bk9GkbUR_cZu9R2RAk130_assertion description "[Protease-activated receptor-1 (PAR-1) and PAR-2 are overexpressed in cancer cells and activation of these receptors contributes to malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390531.RAKgAvnJ_zTfnbA9oLtOgrsVJK4bk9GkbUR_cZu9R2RAk130_provenance.
- NP916303.RAvbG0I3W4gA0IxwT1mly6GVcaKdODYhoLoNKdFsEdN4Y130_assertion description "[Protease-activated receptor-1 (PAR-1) and PAR-2 are overexpressed in cancer cells and activation of these receptors contributes to malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916303.RAvbG0I3W4gA0IxwT1mly6GVcaKdODYhoLoNKdFsEdN4Y130_provenance.
- NP916214.RAJKN5UMOV2n2SBPBn1SxVNo5AU9VoPDlOZH9DdwFfmNg130_assertion description "[Protease-activated receptor-1 (PAR-1) and PAR-2 are overexpressed in cancer cells and activation of these receptors contributes to malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916214.RAJKN5UMOV2n2SBPBn1SxVNo5AU9VoPDlOZH9DdwFfmNg130_provenance.